{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T06:32:52Z","timestamp":1787380372035,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03778-4","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T14:02:42Z","timestamp":1740578562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A scoping review of the extent of the clinical research on the vitiligo extent score"],"prefix":"10.1007","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8426-8984","authenticated-orcid":false,"given":"S.","family":"Orozco-Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5976-2518","authenticated-orcid":false,"given":"P. A.","family":"Rueda-Galvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2418-6159","authenticated-orcid":false,"given":"C. E.","family":"Builes-Monta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1523-4104","authenticated-orcid":false,"given":"A.","family":"Arango-Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"issue":"3","key":"3778_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/1346-8138.15743","volume":"48","author":"C Bergqvist","year":"2021","unstructured":"Bergqvist C, Ezzedine K, Vitiligo (2021) A focus on pathogenesis and its therapeutic implications. J Dermatol 48(3):252\u2013270","journal-title":"J Dermatol"},{"key":"3778_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jaut.2005.10.001","volume":"25","author":"T Passeron","year":"2005","unstructured":"Passeron T, Ortonne JP (2005) Physiopathology and genetics of vitiligo. J Autoimmun 25:63\u201368","journal-title":"J Autoimmun"},{"issue":"4","key":"3778_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-0625.1993.tb00023.x","volume":"2","author":"IC Le Poole","year":"1993","unstructured":"Le Poole IC, Das PK, van den Wijngaard RM, Bos JD, Westerhof W (1993) Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 2(4):145\u2013153","journal-title":"Exp Dermatol"},{"issue":"6","key":"3778_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s40257-021-00631-6","volume":"22","author":"K Ezzedine","year":"2021","unstructured":"Ezzedine K, Eleftheriadou V, Jones H, Bibeau K, Kuo FI, Sturm D et al (2021) Psychosocial effects of Vitiligo: a systematic literature review. Am J Clin Dermatol 22(6):757\u2013774","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"3778_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","volume":"77","author":"M Rodrigues","year":"2017","unstructured":"Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE (2017) New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol 77(1):1\u201313","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"3778_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4103\/0019-5154.119949","volume":"58","author":"VR Attili","year":"2013","unstructured":"Attili VR, Attili SK (2013) Segmental and generalized vitiligo: both forms demonstrate inflammatory histopathological features and clinical mosaicism. Indian J Dermatol 58(6):433\u2013438","journal-title":"Indian J Dermatol"},{"key":"3778_CR7","doi-asserted-by":"publisher","first-page":"5617838","DOI":"10.1155\/2017\/5617838","volume":"2017","author":"V Vachiramon","year":"2017","unstructured":"Vachiramon V, Onprasert W, Harnchoowong S, Chanprapaph K (2017) Prevalence and Clinical Characteristics of Itch in Vitiligo and its clinical significance. Biomed Res Int 2017:5617838","journal-title":"Biomed Res Int"},{"issue":"3","key":"3778_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.clindermatol.2013.11.011","volume":"32","author":"T Lotti","year":"2014","unstructured":"Lotti T, D\u2019Erme AM (2014) Vitiligo as a systemic disease. Clin Dermatol 32(3):430\u2013434","journal-title":"Clin Dermatol"},{"issue":"2","key":"3778_CR9","doi-asserted-by":"publisher","first-page":"e14803","DOI":"10.1111\/dth.14803","volume":"34","author":"N Namazi","year":"2021","unstructured":"Namazi N, Amani M, Haghighatkhah HR, Noori E, Abdollahimajd F (2021) Increased risk of subclinical atherosclerosis and metabolic syndrome in patients with vitiligo: a real association or a coincidence? Dermatol Ther 34(2):e14803","journal-title":"Dermatol Ther"},{"issue":"10","key":"3778_CR10","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/ijd.14055","volume":"57","author":"AM Dahir","year":"2018","unstructured":"Dahir AM, Thomsen SF (2018) Comorbidities in vitiligo: comprehensive review. Int J Dermatol 57(10):1157\u20131164","journal-title":"Int J Dermatol"},{"issue":"3","key":"3778_CR11","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1111\/ajd.13008","volume":"60","author":"ML Peralta-Pedrero","year":"2019","unstructured":"Peralta-Pedrero ML, Morales-S\u00e1nchez MA, Jurado-Santa Cruz F, De la Torre-Garc\u00eda ME, Cruz-Peralta ES, Olgu\u00edn-Garc\u00eda MG (2019) Systematic Review of Clinimetric Instruments to determine the severity of non-segmental Vitiligo. Australas J Dermatol 60(3):e178\u2013e85","journal-title":"Australas J Dermatol"},{"issue":"11","key":"3778_CR12","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1001\/archdermatol.2012.3065","volume":"148","author":"C Vrijman","year":"2012","unstructured":"Vrijman C, Linthorst Homan MW, Limpens J, van der Veen W, Wolkerstorfer A, Terwee CB et al (2012) Measurement properties of outcome measures for vitiligo. A systematic review. Arch Dermatol 148(11):1302\u20131309","journal-title":"Arch Dermatol"},{"issue":"5","key":"3778_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jid.2015.12.040","volume":"136","author":"N van Geel","year":"2016","unstructured":"van Geel N, Lommerts J, Bekkenk M, Wolkerstorfer A, Prinsen CAC, Eleftheriadou V et al (2016) Development and validation of the Vitiligo Extent score (VES): an International Collaborative Initiative. J Invest Dermatol 136(5):978\u2013984","journal-title":"J Invest Dermatol"},{"issue":"4","key":"3778_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/pcmr.12593","volume":"30","author":"N Van Geel","year":"2017","unstructured":"van Geel N, Boniface K, Seneschal J, Jacquemin C, Speeckaert R, Wolkerstorfer A et al (2017) Meeting report: Vitiligo Global issues Consensus Conference Workshop Outcome measurement instruments and Vitiligo International Symposium, Rome, Nov 30\u2013Dec 3rd. Pigment Cell Melanoma Res 30(4):436\u2013443","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"3778_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/XEB.0000000000000050","volume":"13","author":"MD Peters","year":"2015","unstructured":"Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB (2015) Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc 13(3):141\u2013146","journal-title":"Int J Evid Based Healthc"},{"issue":"7","key":"3778_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D et al (2018) PRISMA Extension for scoping reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med 169(7):467\u2013473","journal-title":"Ann Intern Med"},{"issue":"2","key":"3778_CR17","doi-asserted-by":"publisher","first-page":"e070104","DOI":"10.1136\/bmjopen-2022-070104","volume":"13","author":"PA Rueda-Galvis","year":"2023","unstructured":"Rueda-Galvis PA, Orozco-Jim\u00e9nez S, Builes-Monta\u00f1o CE, Arango-Salgado A (2023) Use of the Vitiligo Extent score: a protocol for a scoping review. BMJ Open 13(2):e070104","journal-title":"BMJ Open"},{"issue":"3","key":"3778_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.5195\/jmla.2021.1260","volume":"109","author":"T Gotschall","year":"2021","unstructured":"Gotschall T (2021) EndNote 20 desktop version. J Med Libr Assoc 109(3):520\u2013522","journal-title":"J Med Libr Assoc"},{"key":"3778_CR19","unstructured":"van Geel N, Speeckaert R (2016) Wetenschappelijk onderzoek in Belgi\u00eb: een nieuw scoresysteem voor de beoordeling Van vitiligo en inzichten op gebied Van Therapie, Nederlands Tijdschrift Voor Dermatologie & Venereologie, vol 26 pp 161\u2013162."},{"issue":"5","key":"3778_CR20","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jid.2016.02.006","volume":"136","author":"J Seneschal","year":"2016","unstructured":"Seneschal J, Boniface K (2016) A score with a VESted interest in Vitiligo. J Invest Dermatol 136(5):902\u2013904","journal-title":"J Invest Dermatol"},{"issue":"3","key":"3778_CR21","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jaad.2016.09.034","volume":"76","author":"N van Geel","year":"2017","unstructured":"van Geel N, Lommerts JE, Bekkenk MW, Prinsen CA, Eleftheriadou V, Taieb A et al (2017) Development and validation of a patient-reported outcome measure in vitiligo: the Self Assessment Vitiligo Extent score (SA-VES). J Am Acad Dermatol 76(3):464\u2013471","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3778_CR22","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jaad.2017.11.032","volume":"78","author":"N van Geel","year":"2018","unstructured":"van Geel N, Wolkerstorfer A, Lommerts JE, Ezzedine K, Eleftheriadou V, Hamzavi I et al (2018) Validation study of the Vitiligo Extent score-plus. J Am Acad Dermatol 78(5):1013\u20131015","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"3778_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jaad.2017.12.070","volume":"79","author":"N van Geel","year":"2018","unstructured":"van Geel N, Bekkenk M, Lommerts JE, Ezzedine K, Harris J, Hamzavi I et al (2018) The Vitiligo Extent score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo. J Am Acad Dermatol 79(2):369\u2013371","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3778_CR24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/pcmr.12784","volume":"32","author":"N van Geel","year":"2019","unstructured":"van Geel N, Wolkerstorfer A, Ezzedine K, Pandya AG, Bekkenk M, Grine L et al (2019) Validation of a physician global assessment tool for vitiligo extent: results of an international vitiligo expert meeting. Pigment Cell Melanoma Res 32(5):728\u2013733","journal-title":"Pigment Cell Melanoma Res"},{"issue":"4","key":"3778_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4103\/ijdvl.IJDVL_49_18","volume":"85","author":"RM Mogawer","year":"2019","unstructured":"Mogawer RM, Elmasry MF, Mostafa WZ (2019) New insights into leukotrichia in nonsegmental vitiligo: a cross-sectional study. Indian J Dermatol Venereol Leprol 85(4):374\u2013379","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"3778_CR26","first-page":"129","volume":"64","author":"A Casta\u00f1o-Villegas","year":"2020","unstructured":"Casta\u00f1o-Villegas A, Moreno-Zuluaga C, Mart\u00ednez-Villaba AR, Medina-Alvis L, Valencia-Ocampo OJ (2020) Concentraciones s\u00e9ricas de vitamina D y su asociaci\u00f3n con la gravedad cl\u00ednica del vit\u00edligo en pacientes que asisten a un servicio de fototerapia. Dermatol Rev Mex 64(2):129\u2013143","journal-title":"Dermatol Rev Mex"},{"issue":"2","key":"3778_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/pcmr.12730","volume":"32","author":"JM Bae","year":"2019","unstructured":"Bae JM, Oh SH, Kang HY, Ryoo YW, Lan CE, Xiang LH et al (2019) Development and validation of the Vitiligo Extent score for a Target Area (VESTA) to assess the treatment response of a target lesion. Pigment Cell Melanoma Res 32(2):315\u2013319","journal-title":"Pigment Cell Melanoma Res"},{"issue":"10","key":"3778_CR28","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1111\/jocd.13311","volume":"19","author":"RM Mogawer","year":"2020","unstructured":"Mogawer RM, Mostafa WZ, Elmasry MF (2020) Comparative analysis of the body surface area calculation method used in vitiligo extent score vs the hand unit method used in vitiligo area severity index. J Cosmet Dermatol 19(10):2679\u20132683","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"3778_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jdv.16562","volume":"35","author":"N van Geel","year":"2021","unstructured":"van Geel N, Uitentuis SE, Zuidgeest M, Wolkerstorfer A, Bekkenk MW, Moock C et al (2021) Validation of a Patient Global Assessment for extent, severity and impact to define the severity strata for the Self Assessment Vitiligo Extent score (SA-VES). J Eur Acad Dermatol Venereol 35(1):216\u2013221","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"3778_CR30","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.jaad.2020.10.061","volume":"85","author":"SE Uitentuis","year":"2021","unstructured":"Uitentuis SE, Wolkerstorfer A, Bae JM, Esmat S, Mogawer RM, Ragab N et al (2021) Assessing the minimal important change in the vitiligo extent score and the self-assessment vitiligo extent score. J Am Acad Dermatol 85(5):1363\u20131364","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"3778_CR31","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1111\/jdv.17331","volume":"35","author":"E Fontas","year":"2021","unstructured":"Fontas E, Montaudi\u00e9 H, Passeron T (2021) Oral gliadin-protected superoxide dismutase in addition to phototherapy for treating non-segmental vitiligo: a 24-week prospective randomized placebo-controlled study. J Eur Acad Dermatol Venereol 35(8):1725\u20131729","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"3778_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/jocd.13451","volume":"20","author":"R El-Husseiny","year":"2021","unstructured":"El-Husseiny R, Abd-Elhaleem A, Salah El-Din W, Abdallah M (2021) Childhood vitiligo in Egypt: Clinico-Epidemiologic Profile of 483 patients. J Cosmet Dermatol 20(1):237\u2013242","journal-title":"J Cosmet Dermatol"},{"key":"3778_CR33","doi-asserted-by":"publisher","first-page":"949","DOI":"10.2147\/CCID.S324073","volume":"14","author":"P Chaweekulrat","year":"2021","unstructured":"Chaweekulrat P, Silpa-Archa N, Apinuntham C, Chaiyabutr C, Wongpraparut C, Reliability (2021) Validity and feasibility of the Vitiligo Extent score (VES) and Self-Assessment Vitiligo Extent score (SA-VES) among Vitiligo patients: a cross-cultural validation. Clin Cosmet Investig Dermatol 14:949\u2013957","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"8","key":"3778_CR34","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1111\/jocd.13908","volume":"20","author":"MA Atwa","year":"2021","unstructured":"Atwa MA, Ali SMM, Youssef N, Mahmoud Marie RE (2021) Elevated serum level of interleukin-15 in vitiligo patients and its correlation with disease severity but not activity. J Cosmet Dermatol 20(8):2640\u20132644","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"3778_CR35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.25259\/IJDVL_498_20","volume":"87","author":"M Abdallah","year":"2021","unstructured":"Abdallah M, Nassar A, Samir M, Reda AE, Hassan A, Allam MF et al (2021) Validity and feasibility of the self-assessment vitiligo extent score among Egyptian patients. Indian J Dermatol Venereol Leprol 87(5):723\u2013725","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"11","key":"3778_CR36","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.1111\/jocd.15116","volume":"21","author":"R Weshahy","year":"2022","unstructured":"Weshahy R, Abdelhamid MF, Sayed KS, El Desouky ED, Ramez SA (2022) Efficacy and safety of combined fractional ablative CO2 laser and 5 fluorouracil in the treatment of acral vitiligo: an open, uncontrolled study. J Cosmet Dermatol 21(11):5636\u20135641","journal-title":"J Cosmet Dermatol"},{"key":"3778_CR37","doi-asserted-by":"publisher","first-page":"872458","DOI":"10.3389\/fimmu.2022.872458","volume":"13","author":"CY Ng","year":"2022","unstructured":"Ng CY, Chiu YC, Chan YP, Lin YJ, Chung PH, Chung WH et al (2022) Skin interstitial fluid and plasma multiplex cytokine analysis reveals IFN-\u03b3 signatures and Granzyme B as useful biomarker for activity, Severity and Prognosis Assessment in Vitiligo. Front Immunol 13:872458","journal-title":"Front Immunol"},{"issue":"8","key":"3778_CR38","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1111\/jocd.14612","volume":"21","author":"RE Mahmoud Marie","year":"2022","unstructured":"Mahmoud Marie RE, Adel AM, Abd El-Fadeal NM, Eyada MMK (2022) Interleukin 38 serum level is increased in patients with vitiligo, correlated with disease severity, and associated with signs of disease activity. J Cosmet Dermatol 21(8):3515\u20133521","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"3778_CR39","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/bjd.21246","volume":"187","author":"R Merhi","year":"2022","unstructured":"Merhi R, Canu D, Barnetche T, Duchez E, Gey A, Andreu N et al (2022) Assessment of Vitiligo Area Scoring Index (VASI), Facial-VASI and Vitiligo Extent score using standardized photography of patients with vitiligo. Br J Dermatol 187(3):422\u2013424","journal-title":"Br J Dermatol"},{"issue":"9","key":"3778_CR40","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3390\/medicina57090904","volume":"57","author":"SR Mercuri","year":"2021","unstructured":"Mercuri SR, Di Nicola MR, Brianti P, Bianchi VG, Paolino G (2021) Pilot study on the use of the monocyte-rich platelet-rich plasma in combination with 1927 nm fractional and 308 nm excimer lasers for the treatment of vitiligo. Medicina 57(9):904","journal-title":"Medicina"},{"issue":"2","key":"3778_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A Guideline of selecting and reporting Intraclass correlation coefficients for Reliability Research. J Chiropr Med 15(2):155\u2013163","journal-title":"J Chiropr Med"},{"issue":"2","key":"3778_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4055\/cios.2012.4.2.149","volume":"4","author":"KM Lee","year":"2012","unstructured":"Lee KM, Lee J, Chung CY, Ahn S, Sung KH, Kim TW et al (2012) Pitfalls and important issues in testing reliability using intraclass correlation coefficients in orthopaedic research. Clin Orthop Surg 4(2):149\u2013155","journal-title":"Clin Orthop Surg"},{"issue":"11","key":"3778_CR43","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.jclinepi.2004.04.004","volume":"57","author":"RD Crosby","year":"2004","unstructured":"Crosby RD, Kolotkin RL, Williams GR (2004) An integrated method to determine meaningful changes in health-related quality of life. J Clin Epidemiol 57(11):1153\u20131160","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"3778_CR44","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ejpain.2003.09.004","volume":"8","author":"F Salaffi","year":"2004","unstructured":"Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W (2004) Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain 8(4):283\u2013291","journal-title":"Eur J Pain"},{"issue":"7","key":"3778_CR45","first-page":"e164","volume":"23","author":"S Holla","year":"2024","unstructured":"Holla S, Hurtado ACM, Gonzalez S, Gupta R, Pandya AG, Elbuluk N (2024) Racial and ethnic diversity in Vitiligo clinical trials: a retrospective cross-sectional study assessing demographic reporting of participants. J Drugs Dermatol 23(7):e164\u2013e6","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"3778_CR46","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/bjd.17013","volume":"180","author":"V Eleftheriadou","year":"2019","unstructured":"Eleftheriadou V, Hamzavi I, Pandya AG, Grimes P, Harris JE, Huggins RH et al (2019) International Initiative for outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation. Br J Dermatol 180(3):574\u2013579","journal-title":"Br J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03778-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03778-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03778-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T01:40:52Z","timestamp":1740620452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03778-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3778"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03778-4","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"2 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors certify that they have no affiliation with or are involved with any organization or entity with any financial interest (such as fees, financial aid for education, shares, employment contracts, work as consultants, or any other type of interest) or non-financial interest (such as personal, professional relationships, affiliations, or beliefs) in the topic of interest or any material discussed in this manuscript. Carlos E. Builes-Monta\u00f1o has received consulting or speaker fees from Sanofi, Novo Nordisk, Novartis, and Boehringer Ingelheim.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"498"}}